The Effect of Trasylol on Blood Coagulation after Intravenous Injection

J Gormsen; P Josephsen

doi:10.1055/s-0038-1654110

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1967; 17(01/02): 051-057
DOI: 10.1055/s-0038-1654110

Originalarbeiten - Original Articles - Travaux Originaux

Schattauer GmbH

The Effect of Trasylol on Blood Coagulation after Intravenous Injection

J Gormsen M. D.

¹Medical Department, Sundby Hospital, Copenhagen, Denmark

,

P Josephsen M. D.

¹Medical Department, Sundby Hospital, Copenhagen, Denmark

› Author Affiliations

Abstract

Summary

The in vivo effect of Trasylol® on the thromboplastin generation test, thrombin -generation test, the partial thromboplastin time and the thrombelastography has been examined in 50 patients. Furthermore 34 patients were given one of two preparations of “Trasylol”, distributed for a double-blind control. The dosis of Trasylol varied from 100,000 to 400,000 units. No significant influence on the various tests used was found.

Full Text

References

References
1 Amris G. J. Inhibition of fibrinolytic and thromboplastic activity by Trasylol. X^th Congr. Internat. Soc. Haemat. Stockholm. Abstracts G. 72 (1964).
2 Beck E, Schmutzler R, Duckert F. Inhibition of fibrinolysis and fibrinogenolysis in man: Comparison of epsilon-aminocapronic acid and Kallikrein inhibitor. Thrombos. Diathes. haemorrh. (Stuttg.) 10: 106 1963;
3 Benzer H, Blümel G, Piza F. Experimentelle Untersuchungen über die Wirkungen tryp-tischer und antitryptischer Fermente aus den Eiweiß Stoffwechsel und die Blutgerinnung. Klin. Chir 202: 1 1961;
4 Blombäck B, Blombäck M, Olsson P. Sie (13).
5 Dublier A. H. C, McNicol G. P, Uttley D, Douglas A. S. In vitro and in vivo Studies with Trasylol. X^th Congr. Europ. Soc. Haemat. Strassbourg. Abstracts. 76 (1965).
6 Fletcher A. P, Alkjaersig N, Sherry S. Fibrinolytic Mechanisms and the Development of Thrombolytic Therapy. Amer. J. Med 33: 738 1962;
7 Gormsen J. Heparin Resistance, Thromboplastin Generation and Glass activation. Thrombos. Diathes. haemorrh. (Stuttg.) 6: 144 1961;
8 Gormsen J. Thrombelastography and Hypercoagulability. Acta med. scand 170: 313 1961;
9 Gormsen J. Hageman Factor Deficiency. Thrombos. Diathes. haemorrh. (Stuttg.) 7: 249 1962;
10 Laursen B, Gormsen J. In preparation.
11 Marx R, demente P, Werle E, Appel W. Über die Wirkung von Proteinaseinhibitor-Prä-paraten (Leber-und Parotisinhibitor) auf die extravasale Fibrinolyse, Fibrinogenolyse und Blutgerinnungskonstanten im Menschenblut. Blut IX: 164 1964;
12 Merskey R, Johnson A. J, Pert J. H, Wahl M. Pathogenesis of Fibrinolysis in Defibrination Syndrome : Effect of Heparin Administration. Blood 24: 701 1964;
13 Nordström S, Olsson P, Blombäck M. Thromboplastin-induced Hypercoagulability and its Prevention. Nature (Lond.) 206: 632 1965;
14 Olsson P, Nordström S. The Significance of postoperative variations in antithrombins. Thoraxchirurgie 12: 176 1964;